[EN] STRAIGHT-CHAIN AND BRANCHED-CHAIN LIPID COMPOUNDS AS SELECTIVE INHIBITORS OF CYCLOOXYGENASE-2, ANTI-INFLAMMATORY AGENTS, AND ANTI-CANCER AGENTS [FR] COMPOSES LIPIDIQUES A CHAINE RAMIFIEE ET A CHAINE LINEAIRE UTILISES EN TANT QU'INHIBITEURS SELECTIFS DE LA CYCLOOXYGENASE-2, AGENTS ANTI-INFLAMMATOIRES ET AGENTS ANTICANCEREUX
[EN] STRAIGHT-CHAIN AND BRANCHED-CHAIN LIPID COMPOUNDS AS SELECTIVE INHIBITORS OF CYCLOOXYGENASE-2, ANTI-INFLAMMATORY AGENTS, AND ANTI-CANCER AGENTS<br/>[FR] COMPOSES LIPIDIQUES A CHAINE RAMIFIEE ET A CHAINE LINEAIRE UTILISES EN TANT QU'INHIBITEURS SELECTIFS DE LA CYCLOOXYGENASE-2, AGENTS ANTI-INFLAMMATOIRES ET AGENTS ANTICANCEREUX
申请人:YANG ZHENHUA
公开号:WO2005014528A1
公开(公告)日:2005-02-17
Unique branched-chain lipid compounds are disclosed as selective COX-2 inhibitors, which are derivatives of a branched-chain fatty amine or a branched-chain fatty amide, or a pharmaceutically acceptable salt thereof. The compounds can be used for osteoarthritis and rheumatoid arthritis as anti-inflammatory agents, in addition to treating and preventing cancer. Straight-chain analogs of the branched-chain lipid compounds provide similar uses.